Clinical Operations, • 9/19/25 Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Previous Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Next Optimizing CRO and Vendor Selection - Examples from the Field You Might Also Like Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Optimizing CRO and Vendor Selection - Examples from the Field Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials
Clinical Operations, • 9/19/25 Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Previous Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Next Optimizing CRO and Vendor Selection - Examples from the Field You Might Also Like Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Optimizing CRO and Vendor Selection - Examples from the Field Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials
